| 发明名称 |
TOFACITINIB ORAL SUSTAINED RELEASE DOSAGE FORMS |
| 摘要 |
<p>The present invention relates to oral sustained release formulations of tofacitinib and pharmaceutical acceptable salts thereof. The formulations described herein have desirable pharmacokinetic characteristics.</p> |
| 申请公布号 |
CA2905604(A1) |
申请公布日期 |
2014.09.25 |
| 申请号 |
CA20142905604 |
申请日期 |
2014.03.12 |
| 申请人 |
PFIZER INC. |
发明人 |
HERBIG, SCOTT MAX;KRISHNASWAMI, SRIRAM;KUSHNER, JOSEPH, IV;LAMBA, MANISHA;STOCK, THOMAS C. |
| 分类号 |
A61K9/14;A61K9/20;A61K9/28;A61K31/519;A61P1/04;A61P17/06;A61P19/02;A61P37/06 |
主分类号 |
A61K9/14 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
